darunavir/cobicistat/emtricitabine/tenofovir alafenamide
Switching to Symtuza for HIV Maintains High Virologic Suppression Without Drug Resistance
Changing the treatment regimen of adults with HIV who had suppressed viral loads to Symtuza did not increase their ...
NOVEMBER 16, 2018
Switching to Symtuza for HIV Maintains High Virologic Suppression Without Drug Resistance
Adults with HIV who are virologically suppressed maintained that suppression and low virologic failure after ...
OCTOBER 5, 2018
Switching to a D/C/F/TAF Regimen
Gregory D. Huhn, MD, discusses an analysis of 48-week data from the EMERALD trial in subgroups based on age, gender ...
MAY 30, 2018
Load more